EXICURE, INC.

Profile

Company Names

EXICURE, INC.
MAX-1 ACQUISITION CORP

Addresses

8045 LAMON AVE, SUITE 410, SKOKIE, IL 60077

2255 GLADES RD., SUITE 324A, BOCA RATON, FL 33431

Phone Numbers

847-673-1700
(561) 989-2208

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$65,098,271.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2018-08-22 
$22,001,477.00 
$22,001,477.00 
$0.00 
Equity 
2
2017-09-26 
$43,090,544.00 
$43,090,544.00 
$0.00 
Equity 
1
2017-06-16 
$6,250.00 
$6,250.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVID 
A. 
GILJOHANN 
EXECUTIVE OFFICER, DIRECTOR
AURASENSE THERAPEUTICS, LLC   |  EXICURE, INC.   |  EXICURE, INC.
IAN 
 
JACOBS 
EXECUTIVE OFFICER, DIRECTOR
402 FUND LP   |  MAX-1 ACQUISITION CORP   |  ODYSSEY SEMICONDUCTOR TECHNOLOGIES, INC.   |  POWERFLEET, INC.
EKAMBAR 
 
KANDIMALLA 
EXECUTIVE OFFICER
EXICURE, INC.
HELEN 
S. 
KIM 
DIRECTOR
EXICURE, INC.   |  EXICURE, INC.   |  A2 BIOTHERAPEUTICS, INC.   |  ICONOVIR BIO, INC.   |  RECODE THERAPEUTICS, INC.   |  AKTIS ONCOLOGY, INC.
CHAD 
 
MIRKIN 
DIRECTOR
AURASENSE LLC   |  EXICURE, INC.   |  STOICHEIA, INC.   |  AZUL 3D, INC.
MATTHIAS 
 
SCHROFF 
EXECUTIVE OFFICER
EXICURE, INC.   |  INCEPTOR BIO, LLC
DAVID 
S. 
SNYDER 
EXECUTIVE OFFICER
CELLULAR DYNAMICS INTERNATIONAL, INC.   |  EXICURE, INC.   |  EXICURE, INC.
C. 
SHAD 
THAXTON 
DIRECTOR
AURASENSE THERAPEUTICS, LLC   |  EXICURE, INC.   |  EXICURE, INC.
MARK 
 
TOMPKINS 
DIRECTOR
MAX-1 ACQUISITION CORP
JAY 
R. 
VENKATESAN 
DIRECTOR
EXICURE, INC.   |  EXICURE, INC.   |  ANGION BIOMEDICA CORP.
DAVID 
R. 
WALT 
DIRECTOR
ULTIVUE, INC.   |  EXICURE, INC.   |  CERULEAN PHARMA INC.   |  ARBOR BIOTECHNOLOGIES, INC.   |  EXICURE, INC.   |  QUANTERIX CORP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-08-31
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-08-22 
2017-10-10
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-09-26 
2017-10-10
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-09-26 
2017-07-03
D
Link
OTHER 
BLANK CHECKS [6770] 
DECLINE TO DISCLOSE 
Equity 
2017-06-16 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
KATALYST SECURITIES LLC
112494
NONE
NONE
LADENBURG THALMANN + CO. INC.
505
NONE
NONE
CASTLE HILL CAPITAL PARTNERS, INC.
44131
NONE
NONE
KATALYST SECURITIES LLC
112494
NONE
NONE
BENJAMIN + JEROLD BROKERAGE I, LLC
29110